• Meghan G. Lubner
  • J. Louis Hinshaw
  • Chris L. Brace
  • Fred T. LeeJr.
Reference work entry


Cryotherapy is a controlled destruction of tissue by freezing. Due to the excellent visualization of the ice ball on imaging and the close correlation between the ice ball and the zone of necrosis, this is a very precise ablation modality. In addition, multiple probes can be used to generate larger ablation zones, and probes can be controlled individually allowing some sculpting of the ice ball. Cryotherapy may be less sensitive to “cold sink” effects. However, cryoablation lacks the natural cautery effect of heat-based modalities, may be more time consuming and expensive than radiofrequency ablation, and has risk for cryoshock with large volume ablations. In this chapter, we will review the indications, technique, and management of patients undergoing cryoablation.


Renal Cell Carcinoma Ablation Zone Tumor Lysis Syndrome Local Tumor Progression Probe Placement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002;60(2 Suppl 1):40–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Cooper SM, Dawber RP. The history of cryosurgery. J R Soc Med. 2001;94(4):196–201.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Rupp CC, Hoffmann NE, Schmidlin FR, Swanlund DJ, Bischof JC, Coad JE. Cryosurgical changes in the porcine kidney: histologic analysis with thermal history correlation. Cryobiology. 2002;45(2):167–82.PubMedCrossRefGoogle Scholar
  4. 4.
    Rubinsky B, Lee CY, Bastacky J, Onik G. The process of freezing and the mechanism of damage during hepatic cryosurgery. Cryobiology. 1990;27(1):85–97.PubMedCrossRefGoogle Scholar
  5. 5.
    Weber SM, Lee Jr FT, Warner TF, Chosy SG, Mahvi DM. Hepatic cryoablation: US monitoring of extent of necrosis in normal pig liver. Radiology. 1998;207(1):73–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Zacarian SA. The observation of freeze-thaw cycles upon cancer-cell suspensions. J Dermatol Surg Oncol. 1977;3(2):173–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology. 2005;235(1):289–98.PubMedCrossRefGoogle Scholar
  8. 8.
    Badwan K, Maxwell K, Venkatesh R, et al. Comparison of laparoscopic and percutaneous cryoablation of renal tumors: a cost analysis. J Endourol. 2008;22(6):1275–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Bandi G, Hedican S, Moon T, Lee FT, Nakada SY. Comparison of postoperative pain, convalescence, and patient satisfaction after laparoscopic and percutaneous ablation of small renal masses. J Endourol. 2008;22(5):963–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Finley DS, Beck S, Box G, et al. Percutaneous and laparoscopic cryoablation of small renal masses. J Urol. 2008;180(2):492–8. discussion 8.PubMedCrossRefGoogle Scholar
  11. 11.
    Hinshaw JL, Shadid AM, Nakada SY, Hedican SP, Winter 3rd TC, Lee Jr FT. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses. AJR Am J Roentgenol. 2008;191(4):1159–68.PubMedCrossRefGoogle Scholar
  12. 12.
    Hui GC, Tuncali K, Tatli S, Morrison PR, Silverman SG. Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates. J Vasc Interv Radiol. 2008;19(9):1311–20.PubMedCrossRefGoogle Scholar
  13. 13.
    Cervone A, Sardi A, Conaway GL. Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Am Surg. 2000;66(7):611–5.PubMedGoogle Scholar
  14. 14.
    Leen E, Ceccotti P, Moug SJ, et al. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? Ann Surg. 2006;243(2):236–40.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Silverman SG, Tuncali K, Adams DF, et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology. 2000;217(3):657–64.PubMedCrossRefGoogle Scholar
  16. 16.
    Lee Jr FT, Chosy SG, Littrup PJ, Warner TF, Kuhlman JE, Mahvi DM. CT-monitored percutaneous cryoablation in a pig liver model: pilot study. Radiology. 1999;211(3):687–92.PubMedCrossRefGoogle Scholar
  17. 17.
    Littrup PJ, Jallad B, Vorugu V, et al. Lethal isotherms of cryoablation in a phantom study: effects of heat load, probe size, and number. J Vasc Interv Radiol. 2009;20(10):1343–51.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Auge BK, Santa-Cruz RW, Polascik TJ. Effect of freeze time during renal cryoablation: a swine model. J Endourol. 2006;20(12):1101–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Silverman SG, Tuncali K, van Sonnenberg E, et al. Renal tumors: MR imaging-guided percutaneous cryotherapy–initial experience in 23 patients. Radiology. 2005;236(2):716–24.PubMedCrossRefGoogle Scholar
  20. 20.
    Silverman SG, Sun MR, Tuncali K, et al. Three-dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases. AJR Am J Roentgenol. 2004;183(3):707–12.PubMedCrossRefGoogle Scholar
  21. 21.
    Neel 3rd HB, Ketcham AS, Hammond WG. Requisites for successful cryogenic surgery of cancer. Arch Surg. 1971;102(1):45–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Mala T, Edwin B, Tillung T, Kristian Hol P, Soreide O, Gladhaug I. Percutaneous cryoablation of colorectal liver metastases: potentiated by two consecutive freeze-thaw cycles. Cryobiology. 2003;46(1):99–102.PubMedCrossRefGoogle Scholar
  23. 23.
    Robinson D, Halperin N, Nevo Z. Two freezing cycles ensure interface sterilization by cryosurgery during bone tumor resection. Cryobiology. 2001;43(1):4–10.PubMedCrossRefGoogle Scholar
  24. 24.
    Woolley ML, Schulsinger DA, Durand DB, Zeltser IS, Waltzer WC. Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction following renal cryoablation. J Endourol. 2002;16(7):519–22.PubMedCrossRefGoogle Scholar
  25. 25.
    Cooper IS, Hirose T. Application of cryogenic surgery to resection of parenchymal organs. N Engl J Med. 1966;274(1):15–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Allaf ME, Varkarakis IM, Bhayani SB, Inagaki T, Kavoussi LR, Solomon SB. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation–initial observations. Radiology. 2005;237(1):366–70.PubMedCrossRefGoogle Scholar
  27. 27.
    Kuszyk BS, Choti MA, Urban BA, et al. Hepatic tumors treated by cryosurgery: normal CT appearance. AJR Am J Roentgenol. 1996;166(2):363–8.PubMedCrossRefGoogle Scholar
  28. 28.
    McLoughlin RF, Saliken JF, McKinnon G, Wiseman D, Temple W. CT of the liver after cryotherapy of hepatic metastases: imaging findings. AJR Am J Roentgenol. 1995;165(2):329–32.PubMedCrossRefGoogle Scholar
  29. 29.
    Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology. 2002;223(1):255–62.PubMedCrossRefGoogle Scholar
  30. 30.
    Goldberg SN, Charboneau JW, Dodd 3rd GD, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology. 2003;228(2):335–45.PubMedCrossRefGoogle Scholar
  31. 31.
    Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005;235(3):728–39.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Atwell TD, Farrell MA, Leibovich BC, et al. Percutaneous renal cryoablation: experience treating 115 tumors. J Urol. 2008;179(6):2136–40. discussion 40–1.PubMedCrossRefGoogle Scholar
  33. 33.
    Breen DJ, Rutherford EE, Stedman B, et al. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Intervent Radiol. 2007;30(5):936–42.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005;185(1):64–71.PubMedCrossRefGoogle Scholar
  35. 35.
    Gill IS, Remer EM, Hasan WA, et al. Renal cryoablation: outcome at 3 years. J Urol. 2005;173(6):1903–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Littrup PJ, Ahmed A, Aoun HD, et al. CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol. 2007;18(3):383–92.PubMedCrossRefGoogle Scholar
  37. 37.
    Malcolm JB, Berry TT, Williams MB, et al. Single center experience with percutaneous and laparoscopic cryoablation of small renal masses. J Endourol. 2009;23(6):907–11.PubMedCrossRefGoogle Scholar
  38. 38.
    Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol. 2003;180(6):1503–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Park S, Anderson JK, Matsumoto ED, Lotan Y, Josephs S, Cadeddu JA. Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol. 2006;20(8):569–73.PubMedCrossRefGoogle Scholar
  40. 40.
    Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol. 2007;189(2):429–36.PubMedCrossRefGoogle Scholar
  41. 41.
    Atwell TD, Farrell MA, Callstrom MR, et al. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience. Radiology. 2007;243(1):276–83.PubMedCrossRefGoogle Scholar
  42. 42.
    Gupta A, Allaf ME, Kavoussi LR, et al. Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience. J Urol. 2006;175(2):447–52. discussion 52–3.PubMedCrossRefGoogle Scholar
  43. 43.
    Atwell TD, Farrell MA, Callstrom MR, et al. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. AJR Am J Roentgenol. 2007;188(5):1195–200.PubMedCrossRefGoogle Scholar
  44. 44.
    Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170(6 Pt 1):2217–20.PubMedCrossRefGoogle Scholar
  45. 45.
    Allaf ME, Lang E. Bowel separation before percutaneous renal cryoablation. J Urol. 2008;180(2):721.PubMedCrossRefGoogle Scholar
  46. 46.
    Arellano RS, Garcia RG, Gervais DA, Mueller PR. Percutaneous CT-guided radiofrequency ablation of renal cell carcinoma: efficacy of organ displacement by injection of 5% dextrose in water into the retroperitoneum. AJR Am J Roentgenol. 2009;193(6):1686–90.PubMedCrossRefGoogle Scholar
  47. 47.
    Farrell MA, Charboneau JW, Callstrom MR, Reading CC, Engen DE, Blute ML. Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. AJR Am J Roentgenol. 2003;181(5):1315–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Ginat DT, Saad W, Davies M, Walman D, Erturk E. Bowel displacement for CT-guided tumor radiofrequency ablation: techniques and anatomic considerations. J Endourol. 2009;23(8):1259–64.PubMedCrossRefGoogle Scholar
  49. 49.
    Lee SJ, Choyke LT, Locklin JK, Wood BJ. Use of hydrodissection to prevent nerve and muscular damage during radiofrequency ablation of kidney tumors. J Vasc Interv Radiol. 2006;17(12):1967–9.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Park BK, Kim CK. Complications of image-guided radiofrequency ablation of renal cell carcinoma: causes, imaging features and prevention methods. Eur Radiol. 2009;19(9):2180–90.PubMedCrossRefGoogle Scholar
  51. 51.
    Park BK, Kim SH, Byun JY, Kim YS, Kwon GY, Jang IS. CT-guided instillation of 5% dextrose in water into the anterior pararenal space before renal radiofrequency ablation in a porcine model: positive and negative effects. J Vasc Interv Radiol. 2007;18(12):1561–9.PubMedCrossRefGoogle Scholar
  52. 52.
    DeBenedectis CM, Beland MD, Dupuy DE, Mayo-Smith WW. Utility of iodinated contrast medium in hydrodissection fluid when performing renal tumor ablation. J Vasc Interv Radiol. 2010;21(5):745–7.PubMedCrossRefGoogle Scholar
  53. 53.
    Cantwell CP, Wah TM, Gervais DA, et al. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. J Vasc Interv Radiol. 2008;19(7):1034–40.PubMedCrossRefGoogle Scholar
  54. 54.
    Wah TM, Koenig P, Irving HC, Gervais DA, Mueller PR. Radiofrequency ablation of a central renal tumor: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. J Vasc Interv Radiol. 2005;16(11):1551–5.PubMedCrossRefGoogle Scholar
  55. 55.
    Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer. 2008;113(10):2671–80.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Sung GT, Gill IS, Hsu TH, et al. Effect of intentional cryo-injury to the renal collecting system. J Urol. 2003;170(2 Pt 1):619–22.PubMedCrossRefGoogle Scholar
  57. 57.
    Georgiades CS, Hong K, Bizzell C, Geschwind JF, Rodriguez R. Safety and efficacy of CT-guided percutaneous cryoablation for renal cell carcinoma. J Vasc Interv Radiol. 2008;19(9):1302–10.PubMedCrossRefGoogle Scholar
  58. 58.
    Shock SA, Laeseke PF, Sampson LA, et al. Hepatic hemorrhage caused by percutaneous tumor ablation: radiofrequency ablation versus cryoablation in a porcine model. Radiology. 2005;236(1):125–31.PubMedCrossRefGoogle Scholar
  59. 59.
    Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology. 2004;127(5):1372–80.PubMedCrossRefGoogle Scholar
  60. 60.
    El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340(10):745–50.PubMedCrossRefGoogle Scholar
  61. 61.
    Winter TC, Laeseke PF, Lee Jr FT. Focal tumor ablation: a new era in cancer therapy. Ultrasound Q. 2006;22(3):195–217.PubMedCrossRefGoogle Scholar
  62. 62.
    Cagol PP, Pasqual E, Bacchetti S. Natural history of the neoplastic locoregional disease: clinical and pathological patterns. J Exp Clin Cancer Res. 2003;22(4 Suppl):1–4.PubMedGoogle Scholar
  63. 63.
    Duffy JP, Vardanian A, Benjamin E, et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg. 2007;246(3):502–9. discussion 9–11.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Baccarani U, Benzoni E, Adani GL, et al. Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma. Transplant Proc. 2007;39(6):1898–900.PubMedCrossRefGoogle Scholar
  65. 65.
    Komorizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003;97(5):1253–62.PubMedCrossRefGoogle Scholar
  66. 66.
    Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology. 1999;210(3):655–61.PubMedCrossRefGoogle Scholar
  67. 67.
    Lawes D, Chopada A, Gillams A, Lees W, Taylor I. Radiofrequency ablation (RFA) as a cytoreductive strategy for hepatic metastasis from breast cancer. Ann R Coll Surg Engl. 2006;88(7):639–42.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Livraghi T, Goldberg SN, Solbiati L, Meloni F, Ierace T, Gazelle GS. Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology. 2001;220(1):145–9.PubMedCrossRefGoogle Scholar
  69. 69.
    Alseidi A, Helton WS, Espat NJ. Does the literature support an indication for hepatic metastasectomy other than for colorectal primary? J Gastrointest Surg. 2006;10(1):99–104.PubMedCrossRefGoogle Scholar
  70. 70.
    Ahmad A, Chen SL, Bilchik AJ. Role of repeated hepatectomy in the multimodal treatment of hepatic colorectal metastases. Arch Surg. 2007;142(6):526–31. discussion 31–2.PubMedCrossRefGoogle Scholar
  71. 71.
    Ravikumar TS, Kane R, Cady B, Jenkins R, Clouse M, Steele Jr G. A 5-year study of cryosurgery in the treatment of liver tumors. Arch Surg. 1991;126(12):1520–3. discussion 3–4.PubMedCrossRefGoogle Scholar
  72. 72.
    Tuttle TM, Curley SA, Roh MS. Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases. Ann Surg Oncol. 1997;4(2):125–30.PubMedCrossRefGoogle Scholar
  73. 73.
    Pawlik TM, Choti MA. Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg. 2007;11(8):1057–77.PubMedCrossRefGoogle Scholar
  74. 74.
    Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994;343(8910):1405–10.PubMedCrossRefGoogle Scholar
  75. 75.
    Ballantyne GH, Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer. 1993;71(12 Suppl):4252–66.PubMedCrossRefGoogle Scholar
  76. 76.
    Aggarwal S, Chu E. Current therapies for advanced colorectal cancer. Oncology (Williston Park). 2005;19(5):589–95.Google Scholar
  77. 77.
    Goldberg RM. Advances in the treatment of metastatic colorectal cancer. Oncologist. 2005;10(Suppl 3):40–8.PubMedCrossRefGoogle Scholar
  78. 78.
    Emmanouilides C, Sfakiotaki G, Androulakis N, et al. Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study. BMC Cancer. 2007;7:91.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Adam R, Akpinar E, Johann M, Kunstlinger F, Majno P, Bismuth H. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg. 1997;225(1):39–8. discussion 48–50.PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Seifert JK, Morris DL. Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer. Br J Surg. 1999;86(2):234–40.PubMedCrossRefGoogle Scholar
  81. 81.
    Choe YH, Kim SR, Lee KS, et al. The use of PTC and RFA as treatment alternatives with low procedural morbidity in non-small cell lung cancer. Eur J Cancer. 2009;45(10):1773–9.PubMedCrossRefGoogle Scholar
  82. 82.
    Permpongkosol S, Nicol TL, Link RE, et al. Differences in ablation size in porcine kidney, liver, and lung after cryoablation using the same ablation protocol. AJR Am J Roentgenol. 2007;188(4):1028–32.PubMedCrossRefGoogle Scholar
  83. 83.
    Callstrom MR, Kurup AN. Percutaneous ablation for bone and soft tissue metastases–why cryoablation? Skeletal Radiol. 2009;38(9):835–9.PubMedCrossRefGoogle Scholar
  84. 84.
    Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group. Cancer. 1982;50(5):893–9.PubMedCrossRefGoogle Scholar
  85. 85.
    Callstrom MR, Charboneau JW. Image-guided palliation of painful metastases using percutaneous ablation. Tech Vasc Interv Radiol. 2007;10(2):120–31.PubMedCrossRefGoogle Scholar
  86. 86.
    Callstrom MR, Charboneau JW, Goetz MP, et al. Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skeletal Radiol. 2006;35(1):1–15.PubMedCrossRefGoogle Scholar
  87. 87.
    Lessard AM, Gilchrist J, Schaefer L, Dupuy DE. Palliation of recurrent Ewing sarcoma of the pelvis with cryoablation and somatosensory-evoked potentials. J Pediatr Hematol Oncol. 2009;31(1):18–21.PubMedCrossRefGoogle Scholar
  88. 88.
    Meller I, Weinbroum A, Bickels J, et al. Fifteen years of bone tumor cryosurgery: a single-center experience of 440 procedures and long-term follow-up. Eur J Surg Oncol. 2008;34(8):921–7.PubMedCrossRefGoogle Scholar
  89. 89.
    Souna BS, Belot N, Duval H, Langlais F, Thomazeau H. No recurrences in selected patients after curettage with cryotherapy for grade I chondrosarcomas. Clin Orthop Relat Res. 2010;458:1956–62.CrossRefGoogle Scholar
  90. 90.
    van der Geest IC, de Valk MH, de Rooy JW, Pruszczynski M, Veth RP, Schreuder HW. Oncological and functional results of cryosurgical therapy of enchondromas and chondrosarcomas grade 1. J Surg Oncol. 2008;98(6):421–6.PubMedCrossRefGoogle Scholar
  91. 91.
    Liu DM, Kee ST, Loh CT, et al. Cryoablation of osteoid osteoma: two case reports. J Vasc Interv Radiol. 2010;21(4):586–9.PubMedCrossRefGoogle Scholar
  92. 92.
    Rybak LD. Fire and ice: thermal ablation of musculoskeletal tumors. Radiol Clin North Am. 2009;47(3):455–69.PubMedCrossRefGoogle Scholar
  93. 93.
    Byas-Smith MG, Gulati A. Ultrasound-guided intercostal nerve cryoablation. Anesth Analg. 2006;103(4):1033–5.PubMedCrossRefGoogle Scholar
  94. 94.
    Moore W, Kolnick D, Tan J, Yu HS. CT guided percutaneous cryoneurolysis for post thoracotomy pain syndrome early experience and effectiveness. Acad Radiol. 2010;17:603–6.PubMedCrossRefGoogle Scholar
  95. 95.
    Hunt I, Eaton D, Maiwand O, Anikin V. Video-assisted intercostal nerve cryoablation in managing intractable chest wall pain. J Thorac Cardiovasc Surg. 2010;139(3):774–5.PubMedCrossRefGoogle Scholar
  96. 96.
    Robinson JW, Donnelly BJ, Siever JE, et al. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer: quality of life outcomes. Cancer. 2009;115(20):4695–704.PubMedCrossRefGoogle Scholar
  97. 97.
    Bahn DK, Lee F, Silverman P, et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer. 2003;2(2):111–4.PubMedCrossRefGoogle Scholar
  98. 98.
    Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002;60(2 Suppl 1):3–11.PubMedCrossRefGoogle Scholar
  99. 99.
    Cohen JK. Cryosurgery of the prostate: techniques and indications. Rev Urol. 2004;6(Suppl 4):S20–6.PubMedPubMedCentralGoogle Scholar
  100. 100.
    Donnelly BJ, Saliken JC, Brasher PM, et al. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer. 2010;116(2):323–30.PubMedCrossRefGoogle Scholar
  101. 101.
    Finley DS, Pouliot F, Miller DC, Belldegrun AS. Primary and salvage cryotherapy for prostate cancer. Urol Clin North Am. 2010;37(1):67–82. Table of Contents.PubMedCrossRefGoogle Scholar
  102. 102.
    Kimura M, Mouraviev V, Tsivian M, Mayes JM, Satoh T, Polascik TJ. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU Int. 2010;105(2):191–201.PubMedCrossRefGoogle Scholar
  103. 103.
    Onik G, Vaughan D, Lotenfoe R, Dineen M, Brady J. The “male lumpectomy”: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol. 2008;26(5):500–5.PubMedCrossRefGoogle Scholar
  104. 104.
    Ritch CR, Katz AE. Update on cryotherapy for localized prostate cancer. Curr Urol Rep. 2009;10(3):206–11.PubMedCrossRefGoogle Scholar
  105. 105.
    Rukstalis DB. The case for cryoablation of prostate cancer. J Endourol. 2008;22(9):2057–8. discussion 9.PubMedCrossRefGoogle Scholar
  106. 106.
    Littrup PJ, Freeman-Gibb L, Andea A, et al. Cryotherapy for breast fibroadenomas. Radiology. 2005;234(1):63–72.PubMedCrossRefGoogle Scholar
  107. 107.
    Littrup PJ, Jallad B, Chandiwala-Mody P, D’Agostini M, Adam BA, Bouwman D. Cryotherapy for breast cancer: a feasibility study without excision. J Vasc Interv Radiol. 2009;20(10):1329–41.PubMedCrossRefGoogle Scholar
  108. 108.
    Zupi E, Piredda A, Marconi D, et al. Directed laparoscopic cryomyolysis: a possible alternative to myomectomy and/or hysterectomy for symptomatic leiomyomas. Am J Obstet Gynecol. 2004;190(3):639–43.PubMedCrossRefGoogle Scholar
  109. 109.
    Pansky M, Cowan BD, Frank M, Hampton HL, Zimberg S. Laparoscopically assisted uterine fibroid cryoablation. Am J Obstet Gynecol. 2009;201(6):571 e1–7.CrossRefGoogle Scholar
  110. 110.
    Kumar S, Suneetha PV, Dadhwal V, Mittal S. Endometrial cryoablation in the treatment of dysfunctional uterine bleeding. Int J Gynaecol Obstet. 2002;76(2):189–90.PubMedCrossRefGoogle Scholar
  111. 111.
    Beland MD, Dupuy DE, Mayo-Smith WW. Percutaneous cryoablation of symptomatic extraabdominal metastatic disease: preliminary results. AJR Am J Roentgenol. 2005;184(3):926–30.PubMedCrossRefGoogle Scholar
  112. 112.
    Kujak JL, Liu PT, Johnson GB, Callstrom MR. Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Skeletal Radiol. 2010;39(2):175–82.PubMedCrossRefGoogle Scholar
  113. 113.
    Beland MD, Mayo-Smith WW. Ablation of adrenal neoplasms. Abdom Imaging. 2009;34(5):588–92.PubMedCrossRefGoogle Scholar
  114. 114.
    Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb. 1998;43(3):141–54.PubMedGoogle Scholar
  115. 115.
    Zhou XD, Tang ZY, Yang BH, et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer. 2001;91(8):1479–86.PubMedCrossRefGoogle Scholar
  116. 116.
    Xu KC, Niu LZ, He WB, Guo ZQ, Hu YZ, Zuo JS. Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma. World J Gastroenterol. 2003;9(12):2686–9.PubMedPubMedCentralCrossRefGoogle Scholar
  117. 117.
    Riley DK, Babinchak TJ, Zemel R, Weaver ML, Rotheram EB. Infectious complications of hepatic cryosurgery. Clin Infect Dis. 1997;24(5):1001–3.PubMedCrossRefGoogle Scholar
  118. 118.
    Elias D, Di Pietroantonio D, Gachot B, Menegon P, Hakime A, De Baere T. Liver abscess after radiofrequency ablation of tumors in patients with a biliary tract procedure. Gastroenterol Clin Biol. 2006;30(6–7):823–7.PubMedCrossRefGoogle Scholar
  119. 119.
    Glasgow SC, Ramachandran S, Csontos KA, Jia J, Mohanakumar T, Chapman WC. Interleukin-1beta is prominent in the early pulmonary inflammatory response after hepatic injury. Surgery. 2005;138(1):64–70.PubMedCrossRefGoogle Scholar
  120. 120.
    Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg. 1999;23(2):109–13. discussion 13–4.PubMedCrossRefGoogle Scholar
  121. 121.
    Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226(2):441–51.PubMedCrossRefGoogle Scholar
  122. 122.
    de Baere T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol. 2003;181(3):695–700.PubMedCrossRefGoogle Scholar
  123. 123.
    Yeh CN, Chen MF. Resection of peritoneal implantation of hepatocellular carcinoma after hepatic resection: risk factors and prognostic analysis. World J Surg. 2004;28(4):382–6.PubMedCrossRefGoogle Scholar
  124. 124.
    Yeh CN, Chen MF, Jeng LB. Resection of peritoneal implantation from hepatocellular carcinoma. Ann Surg Oncol. 2002;9(9):863–8.PubMedCrossRefGoogle Scholar
  125. 125.
    Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP. Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg. 2003;197(5):753–8.PubMedCrossRefGoogle Scholar
  126. 126.
    Dodd 3rd GD, Napier D, Schoolfield JD, Hubbard L. Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome. AJR Am J Roentgenol. 2005;185(1):51–7.PubMedCrossRefGoogle Scholar
  127. 127.
    Kahlenberg MS, Volpe C, Klippenstein DL, Penetrante RB, Petrelli NJ, Rodriguez-Bigas MA. Clinicopathologic effects of cryotherapy on hepatic vessels and bile ducts in a porcine model. Ann Surg Oncol. 1998;5(8):713–8.PubMedCrossRefGoogle Scholar
  128. 128.
    Akahane M, Koga H, Kato N, et al. Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. Radiographics. 2005;25(Suppl 1):S57–68.PubMedCrossRefGoogle Scholar
  129. 129.
    Rouviere O, Badet L, Murat FJ, et al. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection. Cardiovasc Intervent Radiol. 2008;31(3):595–603.PubMedCrossRefGoogle Scholar
  130. 130.
    Atwell TD, Wass CT, Charboneau JW, Callstrom MR, Farrell MA, Sengupta S. Malignant hypertension during cryoablation of an adrenal gland tumor. J Vasc Interv Radiol. 2006;17(3):573–5.PubMedCrossRefGoogle Scholar
  131. 131.
    Tsoumakidou G, Buy X, Zickler P, Zupan M, Douchet MP, Gangi A. Life-threatening complication during percutaneous ablation of adrenal gland metastasis: Takotsubo syndrome. Cardiovasc Intervent Radiol. 2009;33:646–9.PubMedCrossRefGoogle Scholar
  132. 132.
    Moszkowicz D, Balian C, Dugue L, Maftouh A, Masmoudi H, Charlier A. [Colonic perforation after radiofrequency ablation of a renal cancer]. J Chir (Paris). 2008;145(4):407–8.CrossRefGoogle Scholar
  133. 133.
    Bodily KD, Atwell TD, Mandrekar JN, et al. Hydrodisplacement in the percutaneous cryoablation of 50 renal tumors. AJR Am J Roentgenol. 2010;194(3):779–83.PubMedCrossRefGoogle Scholar
  134. 134.
    Froemming A, Atwell T, Farrell M, Callstrom M, Leibovich B, Charboneau W. Probe retraction during renal tumor cryoablation: a technique to minimize direct ureteral injury. J Vasc Interv Radiol. 2010;21(1):148–51.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Meghan G. Lubner
    • 1
  • J. Louis Hinshaw
    • 2
  • Chris L. Brace
    • 3
  • Fred T. LeeJr.
    • 4
  1. 1.Department of RadiologyUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  2. 2.Department of RadiologyUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  3. 3.Department of RadiologyUniversity of Wisconsin – MadisonMadisonUSA
  4. 4.Department of RadiologyUniversity of WisconsinMadisonUSA

Personalised recommendations